Expired CME Article

Pneumonia in the Elderly: A Review of Severity Assessment, Prognosis, Mortality, Prevention, and Treatment

Authors: Carol P. Chong, FRACP, Philip R. Street, FRACP


Pneumonia is an increasingly common disease in the elderly due to an aging population. This is a comprehensive literature review outlining the severity assessment, morbidity, mortality, prevention and treatment options. Several models have been postulated to predict severity assessment and prognosis in older patients. Mortality increases with age and functional status is also an independent predictor for short- and long-term mortality. The effectiveness of the pneumococcal vaccine is controversial, whereas the influenza vaccine is universally recommended. Treatment involves antibiotics with the type and method depending on the severity of the pneumonia. However, treatment of nursing home patients is challenging and there are no validated guidelines at present to determine when transfer to the hospital is necessary.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1.Zalacain R, Torres A. Pneumonia in the elderly. Clinical Pulmonary Medicine 2004;11:210–218.
2.Oh E, Weintraub N, Dhanani S. Can we prevent aspiration pneumonia in the nursing home? J Am Med Dir Assoc 2004;5:174–179.
3.Niederman MS, Brito V. Pneumonia in the older patient. Clin Chest Med 2007;28:751–771.
4.Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243–250.
5.Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377–382.
6.Nierderman MS, Mandell MA, Anzueto A, et al. American Thoracic Society: guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001;163:645–651.
7.Myint PK, Kamath AV, Vowler SL, et al. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006;35:286–291.
8.Andrews J, Nadjm B, Gant V, et al. Community-acquired pneumonia. Curr Opin Pulm Med 2003;9:175–180.
9.Ewig S, de Roux A, Bauer T, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004;59:421–427.
10.Seppa Y, Bloigu A, Honkanen PO, et al. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med 2001;161:2709–2713.
11.Conte HA, Chen YT, Mehal W, et al. A prognostic rule for elderly-patients admitted with community-acquired pneumonia. Am J Med 1999;106:20–28.
12.Naughton BJ, Mylotte JM, Tayara A. Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortality. J Am Geriatr Soc 2000;48:1292–1299.
13.Kaplan V, Angus DC, Griffin MF, et al. Hospitalized Community-acquired pneumonia in the elderly: age and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002;165:766–772.
14.Fernandez-Sabe N, Carratala J, Roson B, et al. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine 2003;82:159–169.
15.Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998;105:319–330.
16.Mehr DR, Foxman B, Colombo P. Risk factors for mortality from lower respiratory infections in nursing home patients. J Fam Pract 1992;34:585–591.
17.Fried TR, Gillick MR, Lipsitz LA. Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients and pneumonia. J Gen Intern Med 1995;10:246–250.
18.Muder RR, Brennen C, Swenson DL, et al. Pneumonia in a long-term care facility: a prospective study of outcome. Arch Intern Med 1996;156:2365–2370.
19.Torres OH, Munoz J, Ruiz D, et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc 2004;52:1603–1609.
20.Cornu C, Yzebe D, Leophonte P, et al. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 2001;19:4780–4790.
21.Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994;154:2666–2677.
22.Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747–1755.
23.Chiba H, Ohrui T, Matsui T, et al. Benefits of pneumococcal vaccination for bedridden patients. J Am Geriatr Soc 2004;52:1410.
24.Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453–1460.
25.Dear K, Holden J, Andrews R, et al. Vaccines for preventing pneumococcal infection in adults. Cocharane Database Syst Rev 2003;4:CD000422.
26.Loeb M. Pneumonia in the elderly. Curr Opin Infect Dis 2004;17:127–130.
27.Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278:1333–1339.
28.Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46:1–25.
29.Kaplan V, Angus DC. Community-acquired pneumonia in the elderly. Crit Care Clin 2003;19:729–748.
30.Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518–527.
31.Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis 2004;4:112–124.
32.Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658–666.
33.Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347–382.
34.Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730–1754.
35.Antibiotic working group. Therapeutic guidelines: antibiotic, 13th ed. Melbourne, Therapeutic Guidelines Limited, 2006.
36.Johnson PD, Irving LB, Turnidge JD. Community acquired pneumonia. Med J Aust 2002;176:341–347.
37.Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract 2002;51:709–716.
38.Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer. J Am Geriatr Soc 1997;45:302–306.